zambia
Medicines for Malaria Venture
The Swiss Malaria Group members are operating in almost all malaria endemic countries. With their commitment they are contributing to the global fight against malaria. For more information on our members, please go to the member's website by clicking on the member's logo.
Project 1
Making injectable and rectal artesunate available to vulnerable populations to address severe malaria (--> reduction in deaths of young children with severe malaria from 8% to < 0.5%)
Project 2
Supporting development of a key easy-to-administer and long-protective antimalarial - dihydroartemisinin-piperaquine (Euroartesim).
Syngenta
The Swiss Malaria Group members are operating in almost all malaria endemic countries. With their commitment they are contributing to the global fight against malaria. For more information on our members, please go to the member's website by clicking on the member's logo.
Project 1
Launch of ACTELLIC 300CS for IRS & following establishment of NgenIRS project. The project's aim is to make the most effective, long lasting insecticides available to malaria control programmes to support insecticide resistance management strategies.
Countries
benin burkina-faso ethiopia ghana kenya madagascar mali malawi mozambique rwanda tanzania uganda zambia zimbabwe
Impact
6.7 million units of ACTELLIC procured
Duration
2013/2016 - ongoing
Activity
Vector control